logo
calendar30 Oktabr 2019
view84
Main language:Russian

EFFICIACY OF ANTIDEPRESSANTS IN THE COMPLEX PHARMACOTHERAPY OF NON-SPECIFIC BACK PAIN

Field of Science:
pdf

20191030050037_Farmvest....pdf

PDF

ARTICLE ANNOTATION

quote
Article describes randomized controlled trial with 6 weeks follow up of adults with chronic non-specific back pain. A total of 40 patients were selected, randomized into 2 groups: the control group and the study group. The control group received standard therapy, while the main group received serotonin reuptake inhibitor trazodone. After 6 weeks, it was found that there was a significant reduction in pain (VAS score) and a significant decrease in depression (Hamilton depression rating scale).

AUTHORS

X.Maxammadxodjaeva

Ташкентский институт усовершенствования врачей

E.Mirdjuraev

Ташкентский институт усовершенствования врачей

D.Akilov

Ташкентский институт усовершенствования врачей

Tags

# антидепрессанты# Antidepressants# антидепрессантлар# ВАШ# носпецифик бел оғриғи# люмбалгия# тразодон# Гамильтон шкаласи# неспецифические боли в спине# люмбалгии# шкала Гамильтона# non-specific back pain# low back pain# trazodone# VAS score# Hamilton depression rating scal

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

References

1. Парфенов В.А., Исайкин А.И. Боль в нижней части спины: мифы и реальность. М.: ИМА-ПРЕСС, - 2016. - C. 8–12.

2. Koes B.W., van Tulder M., Lin C.W. et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care // Eur. Spine J. 2010. Vol. 19. № 12. P. 2075–2094.

3. Парфенов В.А., Герасимова О.Н. Неспецифическая боль в спине в амбулаторной практике, применение Аэртала и Мидокалма // Справочник поликлинического врача. - 2013. - № 1. - С. 34–37.

4. Wong J.J., Côté P., Sutton D.A. et al. Clinical practice guidelines for the noninvasive management of low back pain: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration // Eur. J. Pain. 2016. Vol. 21. - № 2. - P. 201–216.

5. Jackson KC, St. Onge EL. Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Pract. - 2003;3:135–143.

6. Yelin E1. Cost of musculoskeletal diseases: impact of work disability and functional decline. J Rheumatol Suppl. - 2003 Dec; 68:8-11.

7. Munce SE, Stewart DE. Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics. 2007 Sep-Oct;48(5):394-9.

8. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Clin J Chronic pain-associated depression: antecedent or consequence of chronic pain? A review Pain, 1997

9. Чистик Татьяна. Роль антидепрессантов в лечении хронического болевого синдрома // Новости медицины и фармации. Неврология. - 2012. - 420 (тематический номер).

10. Frudurique Rodieux, Valurie Piguet, Patricia Berney, Jules Desmeules, Marie Besson. Personalized Medicine. Pharmacogenetics and Analgesic Effects of Antidepressants in Chronic Pain Management. -2015. - 12 (2). - 163-175.